Time to try this warfarin alternative?

dc.contributor.author	Kirley, Kate	eng
dc.contributor.author	Rowland, Kate	eng
dc.contributor.other	Family Physicians Inquiries Network	eng
dc.date.issued	2011	eng
dc.description.abstract	Consider dabigatran, an oral anticoagulant that does not require monitoring, for the prevention of stroke and thromboembolism in patients with atrial fibrillation. Stength of recommendation: B: Based on a single well-done randomized controlled trial (RCT).	eng
dc.identifier.uri	http://hdl.handle.net/10355/10388
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Priority Updates to Research Literature (PURLs) (2011)	eng
dc.relation.ispartofcommunity	University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	Journal of family practice, 60, no. 04 (April 2011): 220-222.	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject.other	Dabigatran	eng
dc.subject.other	Stroke prevention	eng
dc.subject.other	Thromboembolism	eng
dc.subject.other	Atrial fibrillation	eng
dc.subject.other	blood thinner	eng
dc.subject.other	thrombin inhibitor	eng
dc.title	Time to try this warfarin alternative?	eng
dc.type	Article	eng

Priority Updates to Research Literature (PURLs)
Priority Updates to Research Literature generate new evidence-based recommendations for practice for family physicians and other primary care clinicians.